ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 63 filers reported holding ADAMAS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $164,000 | +27.1% | 37,880 | +20.5% | 0.01% | +22.2% |
Q3 2020 | $129,000 | -42.9% | 31,425 | -59.9% | 0.01% | -50.0% |
Q1 2020 | $226,000 | -36.0% | 78,300 | -15.9% | 0.02% | -18.2% |
Q4 2019 | $353,000 | +29.8% | 93,104 | +75.0% | 0.02% | +37.5% |
Q3 2019 | $272,000 | -43.9% | 53,200 | -32.0% | 0.02% | -44.8% |
Q2 2019 | $485,000 | +67.2% | 78,200 | +352.0% | 0.03% | +383.3% |
Q3 2015 | $290,000 | -16.2% | 17,300 | +31.1% | 0.01% | -33.3% |
Q2 2015 | $346,000 | +51.1% | 13,200 | +0.8% | 0.01% | +50.0% |
Q1 2015 | $229,000 | – | 13,100 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 808,431 | $3,501,000 | 2.68% |
AIGH Capital Management LLC | 875,851 | $3,793,000 | 1.54% |
Healthcare Value Capital, LLC | 100,000 | $433,000 | 1.46% |
SILVERARC CAPITAL MANAGEMENT, LLC | 440,955 | $1,909,000 | 1.11% |
Opaleye Management Inc. | 1,487,800 | $6,442,000 | 0.84% |
Worth Venture Partners, LLC | 225,106 | $975,000 | 0.77% |
ARMISTICE CAPITAL, LLC | 2,742,000 | $11,873,000 | 0.40% |
DELTEC ASSET MANAGEMENT LLC | 245,399 | $1,063,000 | 0.16% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 278,011 | $1,204,000 | 0.15% |
Mosaic Family Wealth, LLC | 91,807 | $398,000 | 0.13% |